Logo image of CPAY

CORPAY INC (CPAY) Stock Fundamental Analysis

NYSE:CPAY - New York Stock Exchange, Inc. - US2199481068 - Common Stock - Currency: USD

363.84  -5.15 (-1.4%)

After market: 363.84 0 (0%)

Fundamental Rating

5

CPAY gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Financial Services industry. CPAY scores excellent on profitability, but there are concerns on its financial health. CPAY has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CPAY was profitable.
CPAY had a positive operating cash flow in the past year.
In the past 5 years CPAY has always been profitable.
CPAY had a positive operating cash flow in each of the past 5 years.
CPAY Yearly Net Income VS EBIT VS OCF VS FCFCPAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

CPAY has a better Return On Assets (5.59%) than 81.19% of its industry peers.
CPAY has a Return On Equity of 32.15%. This is amongst the best in the industry. CPAY outperforms 93.07% of its industry peers.
CPAY has a Return On Invested Capital of 12.16%. This is amongst the best in the industry. CPAY outperforms 88.12% of its industry peers.
CPAY had an Average Return On Invested Capital over the past 3 years of 12.51%. This is above the industry average of 7.75%.
Industry RankSector Rank
ROA 5.59%
ROE 32.15%
ROIC 12.16%
ROA(3y)6.24%
ROA(5y)6.25%
ROE(3y)33.21%
ROE(5y)29.98%
ROIC(3y)12.51%
ROIC(5y)11.72%
CPAY Yearly ROA, ROE, ROICCPAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 25.25%, CPAY is in the better half of the industry, outperforming 78.22% of the companies in the same industry.
In the last couple of years the Profit Margin of CPAY has declined.
Looking at the Operating Margin, with a value of 44.18%, CPAY belongs to the top of the industry, outperforming 87.13% of the companies in the same industry.
CPAY's Operating Margin has been stable in the last couple of years.
CPAY has a Gross Margin of 78.13%. This is amongst the best in the industry. CPAY outperforms 85.15% of its industry peers.
CPAY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 44.18%
PM (TTM) 25.25%
GM 78.13%
OM growth 3Y0.25%
OM growth 5Y-1.02%
PM growth 3Y-5.18%
PM growth 5Y-5.66%
GM growth 3YN/A
GM growth 5Y-4.82%
CPAY Yearly Profit, Operating, Gross MarginsCPAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CPAY is destroying value.
Compared to 1 year ago, CPAY has less shares outstanding
CPAY has less shares outstanding than it did 5 years ago.
CPAY has a worse debt/assets ratio than last year.
CPAY Yearly Shares OutstandingCPAY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CPAY Yearly Total Debt VS Total AssetsCPAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.30 indicates that CPAY is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CPAY (2.30) is better than 77.23% of its industry peers.
CPAY has a debt to FCF ratio of 4.53. This is a neutral value as CPAY would need 4.53 years to pay back of all of its debts.
The Debt to FCF ratio of CPAY (4.53) is better than 65.35% of its industry peers.
A Debt/Equity ratio of 2.10 is on the high side and indicates that CPAY has dependencies on debt financing.
CPAY has a Debt to Equity ratio of 2.10. This is in the lower half of the industry: CPAY underperforms 65.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 4.53
Altman-Z 2.3
ROIC/WACC0.9
WACC13.53%
CPAY Yearly LT Debt VS Equity VS FCFCPAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

CPAY has a Current Ratio of 1.00. This is a bad value and indicates that CPAY is not financially healthy enough and could expect problems in meeting its short term obligations.
CPAY's Current ratio of 1.00 is in line compared to the rest of the industry. CPAY outperforms 47.52% of its industry peers.
CPAY has a Quick Ratio of 1.00. This is a bad value and indicates that CPAY is not financially healthy enough and could expect problems in meeting its short term obligations.
CPAY has a Quick ratio (1.00) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
CPAY Yearly Current Assets VS Current LiabilitesCPAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.35% over the past year.
CPAY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.03% yearly.
CPAY shows a small growth in Revenue. In the last year, the Revenue has grown by 5.77%.
Measured over the past years, CPAY shows a quite strong growth in Revenue. The Revenue has been growing by 8.45% on average per year.
EPS 1Y (TTM)12.35%
EPS 3Y12.9%
EPS 5Y10.03%
EPS Q2Q%20.72%
Revenue 1Y (TTM)5.77%
Revenue growth 3Y11.94%
Revenue growth 5Y8.45%
Sales Q2Q%10.36%

3.2 Future

The Earnings Per Share is expected to grow by 17.46% on average over the next years. This is quite good.
Based on estimates for the next years, CPAY will show a quite strong growth in Revenue. The Revenue will grow by 10.03% on average per year.
EPS Next Y13.43%
EPS Next 2Y15.31%
EPS Next 3Y15.67%
EPS Next 5Y17.46%
Revenue Next Year11.59%
Revenue Next 2Y10.75%
Revenue Next 3Y10.18%
Revenue Next 5Y10.03%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CPAY Yearly Revenue VS EstimatesCPAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
CPAY Yearly EPS VS EstimatesCPAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.14 indicates a rather expensive valuation of CPAY.
Compared to the rest of the industry, the Price/Earnings ratio of CPAY is on the same level as its industry peers.
When comparing the Price/Earnings ratio of CPAY to the average of the S&P500 Index (29.63), we can say CPAY is valued slightly cheaper.
The Price/Forward Earnings ratio is 16.87, which indicates a correct valuation of CPAY.
CPAY's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.68. CPAY is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.14
Fwd PE 16.87
CPAY Price Earnings VS Forward Price EarningsCPAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CPAY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CPAY is cheaper than 62.38% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CPAY indicates a somewhat cheap valuation: CPAY is cheaper than 71.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.37
EV/EBITDA 14.64
CPAY Per share dataCPAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 -60

4.3 Compensation for Growth

CPAY's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CPAY may justify a higher PE ratio.
A more expensive valuation may be justified as CPAY's earnings are expected to grow with 15.67% in the coming years.
PEG (NY)1.42
PEG (5Y)1.91
EPS Next 2Y15.31%
EPS Next 3Y15.67%

0

5. Dividend

5.1 Amount

No dividends for CPAY!.
Industry RankSector Rank
Dividend Yield N/A

CORPAY INC

NYSE:CPAY (2/21/2025, 8:10:40 PM)

After market: 363.84 0 (0%)

363.84

-5.15 (-1.4%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)05-06 2025-05-06/amc
Inst Owners96.96%
Inst Owner Change0.77%
Ins Owners3.09%
Ins Owner Change5.08%
Market Cap25.36B
Analysts81.6
Price Target413.77 (13.72%)
Short Float %2.01%
Short Ratio3.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.61%
Min EPS beat(2)-1.78%
Max EPS beat(2)-1.45%
EPS beat(4)0
Avg EPS beat(4)-1.51%
Min EPS beat(4)-1.78%
Max EPS beat(4)-1.06%
EPS beat(8)1
Avg EPS beat(8)-1.44%
EPS beat(12)4
Avg EPS beat(12)-0.27%
EPS beat(16)7
Avg EPS beat(16)0.24%
Revenue beat(2)0
Avg Revenue beat(2)-2.6%
Min Revenue beat(2)-3.5%
Max Revenue beat(2)-1.7%
Revenue beat(4)0
Avg Revenue beat(4)-2.32%
Min Revenue beat(4)-3.5%
Max Revenue beat(4)-1.7%
Revenue beat(8)1
Avg Revenue beat(8)-2.34%
Revenue beat(12)3
Avg Revenue beat(12)-1.25%
Revenue beat(16)6
Avg Revenue beat(16)-0.73%
PT rev (1m)1.51%
PT rev (3m)16.16%
EPS NQ rev (1m)-7.49%
EPS NQ rev (3m)-8.46%
EPS NY rev (1m)-4.52%
EPS NY rev (3m)-4.34%
Revenue NQ rev (1m)-2.81%
Revenue NQ rev (3m)-1.42%
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)0.11%
Valuation
Industry RankSector Rank
PE 19.14
Fwd PE 16.87
P/S 6.38
P/FCF 14.37
P/OCF 13.07
P/B 8.12
P/tB N/A
EV/EBITDA 14.64
EPS(TTM)19.01
EY5.22%
EPS(NY)21.56
Fwd EY5.93%
FCF(TTM)25.32
FCFY6.96%
OCF(TTM)27.84
OCFY7.65%
SpS57.02
BVpS44.79
TBVpS-75.64
PEG (NY)1.42
PEG (5Y)1.91
Profitability
Industry RankSector Rank
ROA 5.59%
ROE 32.15%
ROCE 18.97%
ROIC 12.16%
ROICexc 14.25%
ROICexgc 203.46%
OM 44.18%
PM (TTM) 25.25%
GM 78.13%
FCFM 44.42%
ROA(3y)6.24%
ROA(5y)6.25%
ROE(3y)33.21%
ROE(5y)29.98%
ROIC(3y)12.51%
ROIC(5y)11.72%
ROICexc(3y)14.82%
ROICexc(5y)13.92%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.7%
ROCE(5y)16.97%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y1.06%
ROICexc growth 5Y0.57%
OM growth 3Y0.25%
OM growth 5Y-1.02%
PM growth 3Y-5.18%
PM growth 5Y-5.66%
GM growth 3YN/A
GM growth 5Y-4.82%
F-Score5
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 4.53
Debt/EBITDA 3.11
Cap/Depr 49.9%
Cap/Sales 4.41%
Interest Coverage 3.54
Cash Conversion 92.1%
Profit Quality 175.88%
Current Ratio 1
Quick Ratio 1
Altman-Z 2.3
F-Score5
WACC13.53%
ROIC/WACC0.9
Cap/Depr(3y)47.52%
Cap/Depr(5y)42.51%
Cap/Sales(3y)4.31%
Cap/Sales(5y)4.03%
Profit Quality(3y)145.81%
Profit Quality(5y)152.95%
High Growth Momentum
Growth
EPS 1Y (TTM)12.35%
EPS 3Y12.9%
EPS 5Y10.03%
EPS Q2Q%20.72%
EPS Next Y13.43%
EPS Next 2Y15.31%
EPS Next 3Y15.67%
EPS Next 5Y17.46%
Revenue 1Y (TTM)5.77%
Revenue growth 3Y11.94%
Revenue growth 5Y8.45%
Sales Q2Q%10.36%
Revenue Next Year11.59%
Revenue Next 2Y10.75%
Revenue Next 3Y10.18%
Revenue Next 5Y10.03%
EBIT growth 1Y5.97%
EBIT growth 3Y12.22%
EBIT growth 5Y7.35%
EBIT Next Year34.46%
EBIT Next 3Y19.41%
EBIT Next 5Y17.64%
FCF growth 1Y-9.34%
FCF growth 3Y17.6%
FCF growth 5Y10.19%
OCF growth 1Y-7.64%
OCF growth 3Y17.47%
OCF growth 5Y10.8%